(Q37442261)

English

Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study

scientific article published on 22 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

0 references

0 references

Andrea H Weinberger

2

object named as

Andrea H Weinberger

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1

object named as

Sherry A McKee

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

Emily L R Harrison

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sabrina Coppola

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Tony P George

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

22 August 2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Schizophrenia Research

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

115

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

2-3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

317-324

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

23 August 2017

Co-morbidity of smoking in patients with psychiatric and substance use disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

23 August 2017

Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

23 August 2017

Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

23 August 2017

Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

23 August 2017

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

23 August 2017

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

23 August 2017

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

23 August 2017

Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

23 August 2017

Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

6 September 2017

Smoking and mental illness: A population-based prevalence study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

6 September 2017

Mecamylamine does not precipitate withdrawal in cigarette smokers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

26 June 2018

Signs and symptoms of tobacco withdrawal.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

26 June 2018

Mecamylamine increases nicotine preference and attenuates nicotine discrimination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

26 June 2018

A randomized, controlled trial to assess the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

2 September 2018

A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

2 September 2018

Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

2 September 2018

Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

2 September 2018

Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

2 September 2018

Mecamylamine moderates cue-induced emotional responses in smokers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

2 September 2018

Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

2 September 2018

Mecamylamine acutely increases human intravenous nicotine self-administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

2 September 2018

Mecamylamine increases cigarette smoking in psychiatric patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

2 September 2018

Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2784178

2 September 2018

Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization

1 reference

https://pubmed.ncbi.nlm.nih.gov/19700263

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Smoking and malignancy in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19700263

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level

1 reference

https://pubmed.ncbi.nlm.nih.gov/19700263

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19700263

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.SCHRES.2009.07.019

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37442261&oldid=1766494296"